title: Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis.
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Zonder
authors.forename: Bart
authors.initials: B
authors.lastname: Barlogie
authors.forename: Brian G M
authors.initials: BG
authors.lastname: Durie
authors.forename: Jason
authors.initials: J
authors.lastname: McCoy
authors.forename: John
authors.initials: J
authors.lastname: Crowley
authors.forename: Mohamad A
authors.initials: MA
authors.lastname: Hussein
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use*; D003907:Dexamethasone / Q000009:adverse effects*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D000077269:Lenalidomide; D009101:Multiple Myeloma / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D012307:Risk Factors; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives*; D013923:Thromboembolism / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control*; D013927:Thrombosis / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D013792:Thalidomide; D003907:Dexamethasone; D000077269:Lenalidomide; D001241:Aspirin